PROSPECTS OF PHARMACOLOGICAL TREATMENT OF VASCULAR DEMENTIA IN PATIENTS WITH ARTERIAL HYPERTENSION
##semicolon##
vascular dementiaAbstrak
The article presents research data from 60 patients with vascular dementia. All subjects were divided into 2 groups: 1st group - 30 patients who received choline alfoscerate on the background of basic therapy; and group 2 - 30 patients who received only basic therapy. The effectiveness of therapy was evaluated twice: before treatment and on day 40 of treatment. The status was assessed using the VAS scale (visual-analogue scale for pain), according to the questionnaire for identifying vegetative disorders and determining the vegetative dystonia syndrome (VDS), according to the severity of vegetative reactivity according to the Danyini-Ashner test, and the Hamilton anxiety and depression test. A reliable nootropic effect of the drug was revealed, as well as its effect on cerebrosthenic and somatovegetative manifestations. There were no serious adverse events requiring additional measures.
##submission.citations##
1. Gusev EI, Belousov Yu.B., Boyko AN. and other General principles of pharmacoeconomic research in neurology: Method. recommendations. M.; Publisher E. Razumova, 2003.-56 p.
2. Damulin I.V. Alzheimer's Disease and Vascular Dementia / Ed. N.N. Yah. - M., 2002. -- S. 85.
3. Damulin, I. V. Vascular dementia: pathogenesis, diagnosis and treatment / I. V. Damulin // Farmateka. - 2010. - No. 7. - S. 13–18.
4. Kamchatnov PR., Chugunov A.V., Volovets S.A., Umarova H.Ya. Combination therapy of discirculatory encephalopathy. Consilium medicum. 2005; 7 (8): 686-92.
5. Kamchatnov P.R. Chronic disorders of cerebral circulation, the possibility of metabolic therapy. - breast cancer, volume 16, No. 5, 2008 - p. 274-276.
6. Nikolskaya I.N., Guseva I.A., Bliznevskaya E.V. et al. The role of anxiety disorders in hypertension and the possibility of their correction // Attending physician. - 2007. - No. 3. - S. 89–91.
7. Piradov M.A. Antiplatelet therapy in the prevention of repeated ischemic strokes. - Breast cancer, 2003, volume 11, number 12 with. 696-698.
8. Recommendations of the Russian Medical Society for Arterial Hypertension and the All-Russian Scientific Society of Cardiology. - Appendix 2 to the journal “Cardiovascular Therapy and Prevention” 2008; 7 (6).
9. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 Jan 19;324(7330):141.
10. Doggrell S.A., Evans S. Treatment of dementia with neurotransmission modulation. Expert Opin Investig Drugs 2003; 12:1633—54.
11. Fioravanti M., Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005 ;(2):CD000269.
12. Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003 Jun 28;326(7404):1423.
13. Parnetti L., Amenta F., Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev 2001; 122:2041—55.
